![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Inova Diagnostics’ Assay Cleared by FDA
Inova Diagnostics’ Assay Cleared by FDA
![ClearanceStamp_Gray.gif](https://www.fdanews.com/ext/resources/test/Device_Images6/ClearanceStamp_Gray.gif?t=1576043982&width=430)
August 15, 2018
The FDA granted clearance to Inova Diagnostics’ Quanta Flash HMGCR, a marker that helps to diagnose idiopathic inflammatory myopathy, a group of disorders that involve the inflammation of muscles used for movement.
The assay is one of thirty others cleared by the FDA for use on the Bio-Flash device, a random access chemiluminescent analyzer used in autoimmune laboratories.
Inova’s test can help distinguish between patients with self-limited myopathy who will likely recover and patients who are at severe risk of illness and often need aggressive immunosuppressive therapy.
Upcoming Events
-
21Oct